135 related articles for article (PubMed ID: 6435528)
1. Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1).
Inui K; Wenger DA
Arch Biochem Biophys; 1984 Sep; 233(2):556-64. PubMed ID: 6435528
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts.
Fujibayashi S; Wenger DA
Biochim Biophys Acta; 1986 Feb; 875(3):554-62. PubMed ID: 3081038
[TBL] [Abstract][Full Text] [Related]
3. Studies on a sphingolipid activator protein (SAP-2) in fibroblasts from patients with lysosomal storage diseases, including Niemann-Pick disease Type C.
Fujibayashi S; Wenger DA
Clin Chim Acta; 1985 Mar; 146(2-3):147-56. PubMed ID: 3921288
[TBL] [Abstract][Full Text] [Related]
4. Properties of a protein activator of glycosphingolipid hydrolysis isolated from the liver of a patient with GM1 gangliosidosis, type 1.
Inui K; Wenger DA
Biochem Biophys Res Commun; 1982 Mar; 105(2):745-51. PubMed ID: 6807306
[No Abstract] [Full Text] [Related]
5. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.
Schmid B; Paton BC; Sandhoff K; Harzer K
Hum Genet; 1992 Jul; 89(5):513-8. PubMed ID: 1634229
[TBL] [Abstract][Full Text] [Related]
6. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
[TBL] [Abstract][Full Text] [Related]
7. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis.
Zschoche A; Fürst W; Schwarzmann G; Sanhoff K
Eur J Biochem; 1994 May; 222(1):83-90. PubMed ID: 8200356
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of asparagine-linked sugar chains of sphingolipid activator protein 1 purified from normal human liver and GM1 gangliosidosis (type 1) liver.
Yamashita K; Inui K; Totani K; Kochibe N; Furukawa M; Okada S
Biochemistry; 1990 Mar; 29(12):3030-9. PubMed ID: 2110822
[TBL] [Abstract][Full Text] [Related]
9. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.
Paton BC; Schmid B; Kustermann-Kuhn B; Poulos A; Harzer K
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):481-8. PubMed ID: 1637339
[TBL] [Abstract][Full Text] [Related]
10. The gene coding for a sphingolipid activator protein, SAP-1, is on human chromosome 10.
Inui K; Kao FT; Fujibayashi S; Jones C; Morse HG; Law ML; Wenger DA
Hum Genet; 1985; 69(3):197-200. PubMed ID: 3980013
[TBL] [Abstract][Full Text] [Related]
11. Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts.
Sadeghlar F; Remmel N; Breiden B; Klingenstein R; Schwarzmann G; Sandhoff K
Biochimie; 2003; 85(3-4):439-48. PubMed ID: 12770782
[TBL] [Abstract][Full Text] [Related]
12. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide.
Li SC; Kihara H; Serizawa S; Li YT; Fluharty AL; Mayes JS; Shapiro LJ
J Biol Chem; 1985 Feb; 260(3):1867-71. PubMed ID: 2981875
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and processing of sphingolipid activator protein-2 (SAP-2) in cultured human fibroblasts.
Fujibayashi S; Wenger DA
J Biol Chem; 1986 Nov; 261(32):15339-43. PubMed ID: 3771578
[TBL] [Abstract][Full Text] [Related]
14. Incorporation and degradation of GM1 ganglioside and asialoGM1 ganglioside in cultured fibroblasts from normal individuals and patients with beta-galactosidase deficiency.
Kobayashi T; Shinnoh N; Kuroiwa Y
Biochim Biophys Acta; 1986 Jan; 875(1):115-21. PubMed ID: 3079639
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical localization of sphingolipid activator protein-1, the sulfatide/GM1 ganglioside activator, to lysosomes in human liver and colon.
Tamaru T; Fujibayashi S; Brown WR; Wenger DA
Histochemistry; 1986; 86(2):195-200. PubMed ID: 3028990
[TBL] [Abstract][Full Text] [Related]
16. Assignment of the gene for human sphingolipid activator protein-2 (SAP-2) to chromosome 10.
Fujibayashi S; Kao FT; Jones C; Morse H; Law M; Wenger DA
Am J Hum Genet; 1985 Jul; 37(4):741-8. PubMed ID: 9556662
[TBL] [Abstract][Full Text] [Related]
17. Ganglioside GM1 metabolism in living human fibroblasts with beta-galactosidase deficiency.
Mancini GM; Hoogeveen AT; Galjaard H; Mansson JE; Svennerholm L
Hum Genet; 1986 May; 73(1):35-8. PubMed ID: 3086209
[TBL] [Abstract][Full Text] [Related]
18. Chronic GM1 gangliosidosis presenting as dystonia: II. Biochemical studies.
Kobayashi T; Suzuki K
Ann Neurol; 1981 May; 9(5):476-83. PubMed ID: 6791575
[TBL] [Abstract][Full Text] [Related]
19. GM1-gangliosidosis: accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types.
Suzuki Y; Nakamura N; Fukuoka K
Hum Genet; 1978 Aug; 43(2):127-31. PubMed ID: 99363
[TBL] [Abstract][Full Text] [Related]
20. Immunological evidence for deficiency in an activator protein for sulfatide sulfatase in a variant form of metachromatic leukodystrophy.
Inui K; Emmett M; Wenger DA
Proc Natl Acad Sci U S A; 1983 May; 80(10):3074-7. PubMed ID: 6134282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
